export const communityMedicineData = {
  name: "Community Medicine",
  subtopics: {
    "paper-1": {
      name: "Paper 1",
      subtopics: {
        "man-and-medicine": {
          name: "MAN & MEDICINE",
          "short-notes": {
            name: "Short Notes",
            questions: [
              "1. Changing concepts in public health * (Feb 2009) [Pg.no.8]",
              "2. Health for all * [Pg.no.10]"
            ]
          }
        },
        "concepts-in-health-disease": {
          name: "CONCEPTS IN HEALTH & DISEASE",
          essay: {
            name: "Essay",
            questions: [
              "1. Health? Details about health and indicators * (Aug 2011) [Pg.no.24]",
              "2. Epidemiological triad? Agent, host, Environmental factors? * (Feb 2009) [Pg.no.39]",
              "3. Describe various levels of prevention and interventions with examples. * (Feb 2010) [Pg.no.47]"
            ]
          },
          "short-notes": {
            name: "Short Notes",
            questions: [
              "1. PQLI ***** (Aug 2008, Aug 2011, Feb 2011, Feb 2013, Aug 2018) [Pg.no.17]",
              "2. International classification of diseases ** (Aug 2010, Feb 2012) [Pg.no.56]",
              "3. Primordial prevention ** (Feb 2009, Feb 2012) [Pg.no.48]",
              "4. Ice-berg phenomenon ** (Feb 2009, Feb 2010) [Pg.no.46]",
              "5. Human Development Index * (Feb 2010) [Pg.no.17]",
              "6. Determinants of Health * (Feb 2014) [Pg.no.18]",
              "7. Natural H/o diseases * (Feb 2016) [Pg.no.41]",
              "8. Epidemiological triad * (Aug 2008) [Pg.no.39]",
              "9. Concepts of Prevention * (Aug 2011) [Pg.no.47]",
              "10. Disease Surveillance * (Aug 2008) [Pg.no.47]",
              "11. Rehabilitation * (Aug 2009) [Pg.no.51]",
              "12. Primary prevention * (Feb 2013) [Pg.no.48]",
              "13. Lifestyle and health. * (Aug 2008) [Pg.no.]",
              "14. Proportional mortality rate * (Feb 2009) [Pg.no.25,66]",
              "15. Levels of prevention * (Aug 2011) [Pg.no.47]",
              "16. Define 'agent 'in disease causation. Explain the different types of agents. * (Aug 2012) [Pg.no.43]",
              "17. Human poverty index * (Aug 2013) [Pg.no.17] or HDI",
              "18. Disability limitation * (Feb 2014) [Pg.no.50]",
              "19. Sentinel surveillance * (Feb 2015) [Pg.no.47]",
              "20. Sullivan's index * (Aug 2015) [Pg.no.26] or DFLE",
              "21. What are the modes of intervention in various levels of prevention? * (Feb 2020) [Pg.no.49]",
              "22. Discuss multifactorial etiology and web of causation. * (Apr 2022) [Pg.no.40]",
              "23. Levels of Health Care. * (Feb 2023) [Pg.no.36]",
              "24. What are the various types of Disease Surveillance? * (Feb 2023) [Pg.no.47]",
              "25. Positive health * (Aug 2008) [Pg.no.16]",
              "26. Hospital performance indicator. * [Pg.no.30]"
            ]
          }
        },
        "principles-methods-epidemiology": {
          name: "PRINCIPLES & METHODS OF EPIDEMIOLOGY",
          essay: {
            name: "Essay",
            questions: [
              "1. Define Epidemiology. Discuss briefly the steps of a case-control study. Mention its merits & demerits ** (Aug 2011, Feb 2015) [pg.no.61,79,82]",
              "2. Define source and reservoir of infection? Describe in detail dynamics and modes of disease transmission? * (Aug 2008) [pg.no.102]",
              "3. What are the types of analytical epidemiological study? Describe the steps involved in the case-control study. * (Aug 2009) [pg.no.78]",
              "4. Discuss in detail the steps involved in conducting a cohort study. Mention the advantages and disadvantages of cohort study. * (Feb 2011) [pg.no.83]",
              "5. Define Epidemiology. List the various epidemiological study designs. Briefly discuss the steps in a case control study. * (Feb 2012) [pg.no.61,79]",
              "6. List & define the various types of mortality indicators. What are the uses and limitations of mortality data? Which mortality indicator would you choose to decide the Relative importance of a disease as cause of death in a community? * (Aug 2012) [pg.no.65]",
              "7. Define disinfectant. Discuss in detail about different types of disinfectant. * (Aug 2023) [pg.no.140]",
              "8. Define epidemiology and write the methods in epidemiology. Differentiate between associated factor and causative factor with suitable examples. Write about the relative risk and attributable risk and its applications in public health * (Feb 2018) [pg.no.61,95,86]",
              "9. Classify acute events following immunization (AEFI). Describe the steps in the investigation of an AEFI. * (Feb 2019) [pg.no.123]",
              "10. Define epidemic. Discuss the steps in investigation of an epidemic * (Feb 2020) [pg.no.146]",
              "11. Define Pandemic. Discuss the phases of an Epidemic when an entire population that is susceptible to the infection is exposed to a case. * (Nov 2020) [pg.no.101,147]",
              "12. Enumerate the types of analytical epidemiological study. Describe the steps involved in conducting a cohort study with an example. Mention the advantages and disadvantages of this study design. * (Sep 2021) [pg.no.78]",
              "13. Discuss commonly used mortality rates and ratios. Add a note on uses and limitations of mortality data. * (Apr 2022) [pg.no.65]",
              "14. Define Epidemiology. Enumerate the steps in Case Control Study. Give examples for Case Control Study. * (Feb 2023) [pg.no.61,79]",
              "15. Define Epidemiology. Classify the various Epidemiological studies. Explain in detail the steps in conducting a randomized controlled trial. * (Feb 2023) [pg.no.70,89]"
            ]
          },
          "short-notes": {
            name: "Short Notes",
            questions: [
              "1. Cold chain maintenance and the equipment used for it *** (Aug 2008, Feb 2018, Feb 2022) [pg.no.116]",
              "2. Tools of measurements in epidemiology ** (Aug 2009, Feb 2011) [pg.no.63]",
              "3. Uses of Epidemiology ** (Aug 2013,2016) [pg.no.99]",
              "4. Epidemic curve ** (Aug 2010, Aug 2017) [pg.no.72]",
              "5. Steps in conducting RCT (Randomized Controlled Trials) with an example. ** (Feb 2014, Feb 2022) [pg.no.89]",
              "6. Discuss the steps in the investigation of an epidemic. ** (Feb 2015, Feb 2019) [pg.no.147]",
              "7. Define migration studies. Discuss its use in epidemiology. ** (Aug 2019, Apr 2022) [pg.no.75]",
              "8. Merits & demerits of cohort study * (Aug 2008) [pg.no.87]",
              "9. Incidence rate and its uses * (Aug 2010) [pg.no.68]",
              "10. Elements of Cohort study * (Aug 2010) [pg.no.84]",
              "11. Relative risk and attributable risk * (Aug 2011) [pg.no.86]",
              "12. Describe the steps in doing a Case control study * (Aug 2012) [pg.no.84]",
              "13. Define and give the importance of herd immunity in disease control * (Aug 2012) [pg.no.110]",
              "14. Common Source epidemics * (Feb 2014) [pg.no.103]",
              "15. Adverse events following immunization. * (Feb 2014) [pg.no.123]",
              "16. Monitoring and surveillance. * (Feb 2014) [pg.no.102]",
              "17. Emporiatrics * (Feb 2015) [pg.no.140]",
              "18. Uses of incubation period * (Feb 2015) [pg.no.107]",
              "19. Bias in epidemiological studies * (Feb 2016) [pg.no.81]",
              "20. Write the national immunization schedule * (Feb 2017) [pg.no.125]",
              "21. Define spot map. Discuss its use in epidemiology * (Aug 2018) [pg.no.74]",
              "22. Describe the design of rapid sand filters. * (Aug 2018) [Pg.no.840]",
              "23. Describe the steps in the chlorination of a well * (Feb 2019) [pg.no:844]",
              "24. Discuss the sources of bias in case-control studies and methods of over-coming it. * (Aug 2019) [pg.no.81]",
              "25. Isolation versus quarantine. * (Apr 2022) [pg.no.133]",
              "26. Measures of Dispersion. * (Aug 2022)",
              "27. Mortality data. * (Feb 2023) [pg.no.65]",
              "28. Plan Cold chain model at Primary Health Centre Level for routine immunization. * (Feb 2023) [pg.no.116]",
              "29. Proportional mortality rate * [pg.no.66]",
              "30. Direct standardisation * [pg.no.66]",
              "31. Vaccine vial monitoring * [pg.no.122]",
              "32. Association and causation * [pg.no.95]",
              "33. Additional criteria for judging causality * [pg.no.97]",
              "34. Incubation period * [pg.no.107]",
              "35. Open vial policy * [pg.no.121]"
            ]
          }
        }
      }
    },
    "paper-2": {
      name: "Paper 2",
      subtopics: {}
    }
  }
};